Ramelteon for the treatment of delirium in elderly patients: a consecutive case series study
- PMID: 25084796
- DOI: 10.2190/PM.47.2.a
Ramelteon for the treatment of delirium in elderly patients: a consecutive case series study
Abstract
Objective: Melatonin is effective in the prevention and treatment of delirium. Ramelteon has few adverse effects and higher affinity for MT1 and MT2 receptors than melatonin. The aim of the present study was to determine the efficacy of ramelteon in elderly patients with delirium caused by different primary diseases/conditions.
Method: We treated 10 consecutive elderly patients having delirium with ramelteon.
Results: Of the 10 patients, six showed improvement, and no marked adverse effects were observed.
Conclusions: Our study suggested that ramelteon was a safe and useful alternative to melatonin for the treatment of delirium in elderly patients. Randomized, controlled studies are necessary to confirm the therapeutic benefits of ramelteon.
Keywords: delirium; elderly patients; melatonin; ramelteon.
Similar articles
-
Treatment of delirium with ramelteon: initial experience in three patients.Gen Hosp Psychiatry. 2011 Jul-Aug;33(4):407-9. doi: 10.1016/j.genhosppsych.2011.03.013. Epub 2011 May 20. Gen Hosp Psychiatry. 2011. PMID: 21762839
-
Melatonin receptor agonists for treating delirium in elderly patients with acute stroke.J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1107-10. doi: 10.1016/j.jstrokecerebrovasdis.2012.08.012. Epub 2012 Sep 25. J Stroke Cerebrovasc Dis. 2013. PMID: 23017429
-
[Delirium, insomnia in hospitalization and ramelteon].Nihon Rinsho. 2012 May;70(5):907-13. Nihon Rinsho. 2012. PMID: 22620020 Japanese.
-
Ramelteon for the treatment of insomnia.Clin Ther. 2006 Oct;28(10):1540-55. doi: 10.1016/j.clinthera.2006.10.016. Clin Ther. 2006. PMID: 17157111 Review.
-
Melatonin Receptor Agonists for Delirium Prevention.Ann Pharmacother. 2017 Jan;51(1):72-78. doi: 10.1177/1060028016665863. Epub 2016 Aug 20. Ann Pharmacother. 2017. PMID: 27539735 Review.
Cited by
-
Risk factors, preventive interventions, overlapping symptoms, and clinical measures of delirium in elderly patients.World J Psychiatry. 2023 Dec 19;13(12):973-984. doi: 10.5498/wjp.v13.i12.973. eCollection 2023 Dec 19. World J Psychiatry. 2023. PMID: 38186721 Free PMC article. Review.
-
Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial.Crit Care Med. 2018 Jul;46(7):1099-1105. doi: 10.1097/CCM.0000000000003132. Crit Care Med. 2018. PMID: 29595562 Free PMC article. Clinical Trial.
-
Clinical Practice Guidelines for Management of Delirium in Elderly.Indian J Psychiatry. 2018 Feb;60(Suppl 3):S329-S340. doi: 10.4103/0019-5545.224473. Indian J Psychiatry. 2018. PMID: 29535468 Free PMC article. No abstract available.
-
Melatonin and the Prevention and Management of Delirium: A Scoping Study.Front Med (Lausanne). 2018 Jan 8;4:242. doi: 10.3389/fmed.2017.00242. eCollection 2017. Front Med (Lausanne). 2018. PMID: 29376051 Free PMC article.
-
Adjunctive treatment with melatonin receptor agonists for older delirious patients with the sundowning phenomenon.J Psychiatry Neurosci. 2015 Mar;40(2):E25-6. doi: 10.1503/jpn.140166. J Psychiatry Neurosci. 2015. PMID: 25703643 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
